Communication - IIS Aragón

4 June, 2024

The potential of the tuberculosis vaccine against cancer

Researcher Nacho Aguiló from the University of Zaragoza, the Networked Biomedical Research Center for Respiratory Diseases (Ciberes) and the Aragón Health Research Institute (IIS Aragón), is working to demonstrate, together with his team, that these live vaccines are capable of reverse the effects of asthma and lung and bladder tumors.
3 June, 2024

A new therapeutic approach would reduce mortality from COVID-19

An international study led by Julián Pardo, a researcher at the University of Zaragoza and the IIS Aragón, opens the way to more effective therapies, by reducing inflammation and preventing respiratory failure.
30 May 2024

Estíbaliz Tolosa: “We must promote a culture of excellence in care that translates into quality care for the patient”

Around 180 professionals gathered at the inauguration of the day of excellence of good practices and research projects in care, focused on projects that promote the culture of evidence-based practice.
30 May 2024

The IIS Aragón presents the 'Research and Innovation Awards for Residents'

These distinctions are included in the '5st Research and Innovation Conference for Residents in Aragon', organized this year by the IIS Aragón, taking over from the Miguel Servet University Hospital, which has been at the helm for the last XNUMX years.
29 May 2024

Rebeca Sanz, researcher: “We seek treatment for the 20% of childhood cancer that still has no cure”

eldiario.es interviews Rebeca Sanz, a researcher from Teruel who leads a new group at the Aragón Health Research Institute (IIS Aragón), Cancer Heterogeneity and Immunomics.